SlideShare ist ein Scribd-Unternehmen logo
1 von 60
AMERICAN ASSOCIATION FOR AFFIRMATIVE ACTION  In partnership with New Jersey Affirmative Action Officers’ Council (NJAAOC)  Access, Equity and Diversity Summit  The Atlantic City Convention Center  A  PRESENTATION BY  RONALD W. BROWN, ESQ.
Presentation by Ronald W. Brown, Esq. Recent Legal Developments: A Presentation on the Genetic Information Non-Discrimination Act
AN OVERVIEW OF THE GENETIC INFORMATION NONDISCRIMINATION ACT Presentation by Ronald W. Brown, Esq.
G.I.N.A. IN THE WORKPLACE: CASE SCENARIO While on break at a work water cooler, Carol tells her coworker Bob about the battle her mom is having with Huntington’s disease. Carol tells Bob that “Huntington’s disease is a progressive, degenerative disease” that causes certain nerve cells in the brain to waste away. As a result,” a person may experience uncontrolled movements, emotional disturbances and mental deterioration.”  Carol tells Bob that she fears she is at risk for this genetic disease and that she  periodically uses in the rest room at work, a Direct To Consumer testing kit she purchased over the Internet. Presentation by Ronald W. Brown, Esq.
G.I.N.A. IN THE WORKPLACE:  CASE SCENARIO continued  Carol’s supervisor, Ted, walks by and overhears the conversation. Carol becomes concerned that she may be treated differently by Ted or fired due to her risk for developing HD.  Carol starts reading about the disease during her lunch time at work. Presentation by Ronald W. Brown, Esq.
G.I.N.A. IN THE WORKPLACE:  CASE SCENARIO continued  Presentation by Ronald W. Brown, Esq. Carol starts using “sick days” in order to take her mom to the doctor. At her annual performance review, Ted gives Carol numbers that are so low they will preclude her qualifying for the promotion she wanted and would otherwise get.  Carol had always had stellar reviews in the past. When Carol asks Ted about the numbers, Ted tells her “Carol, you are no longer  a team player. Whenever I really need you here working you are out sick.” He also says, “Carol,  you are not as mentally sharp as you used to be.  You seem to be  emotionally disturbed and deteriorating mentally.  What’s wrong with you?”
G.I.N.A. IN THE WORKPLACE:  CASE SCENARIO #1 continued  Furious, Carol leaves the performance review, goes back to her cubicle. Saying “He does not know who he is messing with!”, she proceeds to  put up  two posters. One reads” Power to the People”.  Every time she passes it she starts chanting: “United, the people, can never be defeated!” The other is A Genetic Bill of Rights poster that reads “All People Have The Right To Be Free From Genetic Discrimination.”  Presentation by Ronald W. Brown, Esq.
G.I.N.A. IN THE WORKPLACE:  CASE SCENARIO #1 continued  Carol also starts coming to work wearing Jeans for Genes  with a button that reads “How my jeans fit or my genes  behave is none of this company’s business!” Presentation by Ronald W. Brown, Esq. Carol comes to you as EEO-AA officer to file a  G.I.N.A. claim. What do you do?
Four Answers to the Question: What Do You Do? 1. If you need it, ask for help from functional “superheroes” with SME, e.g. legal, medical, etc. . 2. Familiarize yourself with what G.I.N.A. is, what it covers, and what it does not cover. 3.  Determine if you need to adapt your normal investigative procedures to fit G.I.N.A. Presentation by Ronald W. Brown, Esq. 4. Focus on answering at least the following two important questions.
G.I.N.A. IN THE WORKPLACE: CASE SCENARIO  Q1. Can Carol be fired or denied a promotion due to her risk of Huntington’s disease? Q2. If Carol needs to take a leave under FMLA to care for her mom, can the employer use the information on the forms to discriminate against Carol?” Presentation by Ronald W. Brown, Esq.
G.I.N.A. Title I Title II Prohibits discrimination in health coverage based on genetic information. Prohibits discrimination in employment based on genetic information. Presentation by Ronald W. Brown, Esq.
WHO ENFORCES G.I.N.A? The Department of Labor, the Department of the Treasury, and the Department of Health and Human Services have specific responsibilities for enforcing the health insurance provisions. Presentation by Ronald W. Brown, Esq. ,[object Object],[object Object]
The Use and Misuse of Genes and Genetic Information Have Popped Up In A Variety of Older Sci-Fi and Film Contexts  Presentation by Ronald W. Brown, Esq.
Genetic Testing Issues Have Popped Up In A More Recent Film  Context “Officially they are called ‘In-valids’…They are the ‘healthy ill’. They don’t actually have anything yet—they may never have. But since few of the pre-conditions can be cured or reversed, it is easier to treat them as if they were already sick.” Pre-G.I.N.A.? Presentation by Ronald W. Brown, Esq.
Genetic Testing Issues Have Popped Up In A Variety of Contexts: Major League Baseball  In July, 2009, Major League Baseball used DNA testing to determine if Miguel Sano, a prospect from the Dominican Republic, was really 16 years old. MLB said that testing in the Dominican Republic is used“ in very rare instances and only on a consensual basis to deal with the identity fraud problem that the league faces in that country.” The statement added that the results of the tests were not used for any other purpose. Presentation by Ronald W. Brown, Esq. Also in July 2009, the New York Yankees voided the signing of an amateur from the Dominican Republic after a DNA test conducted by Major League Baseball’s department of investigations showed that the player had misrepresented his identity.
G.I.N.A.  In A Nutshell The law forbids discrimination on the basis of genetic information when it comes to any aspect of employment, including hiring, firing, pay, job assignments, promotions, layoffs, training, fringe benefits, or any other term or condition of employment.  Genetic information includes information about an individual’s genetic tests and the genetic tests of an individual’s family members, as well as information about any disease, disorder, or condition of an individual’s family members (i.e. an individual’s family medical history).  “An employer may never use genetic information to make an employment decision because genetic information doesn’t tell the employer anything about someone’s current ability to work.” Presentation by Ronald W. Brown, Esq.
G.I.N.A In A Nutshell Title II of G.I.N.A. prohibits use of genetic information in the employment context, restricts employers and other entities covered by Title II from requesting, requiring, or purchasing genetic information, and strictly limits such entities from disclosing genetic information.  Presentation by Ronald W. Brown, Esq.
G.I.N.A. IN A  Nutshell—What Is and What Is Not A Genetic Test? “Genetic test” refers to “analysis of human DNA, RNA, chromosomes, proteins, or metabolites that detects genotypes, mutations, or chromosomal changes.” “Tests to determine whether an individual carries the genetic variant evidencing a predisposition to breast cancer,  colorectal cancer are genetic tests.” “Tests for infectious and communicable diseases that may be transmitted through food handling, complete blood counts, cholesterol tests, and liver-function tests are not genetic tests.” Presentation by Ronald W. Brown, Esq.
G.I.N.A. IN A NUTSHELL Information about race and ethnicity that is not derived from a genetic test is not “genetic information” for  purposes of GINA. Presentation by Ronald W. Brown, Esq.
Gene Testing and State Intervention Overall, 24 states prohibit or limit so-called direct access testing without a doctor or other medical professional’s involvement”—Forbes Presentation by Ronald W. Brown, Esq.
Gene Testing and State Intervention “New York State’s Department of Health sent letters raising the specter of fines and jail time to six online gene-testing firms that offer consumers the ability to pear into their genome to assess the risk of getting disease. Often, it turns out, the services offering these DNA deep-dives are doing so without the involvement of a doctor. That puts them on the wrong side of the law.”--Forbes Presentation by Ronald W. Brown, Esq.
Gene Testing and State Intervention “California’s  Department of Public Health sent cease-and-desist letters to 13 companies that offer gene testing to consumers via the Web. California law requires  that a licensed physician order any lab tests, including genetic tests, All lab tests must also be validated for accuracy and medical utility. These businesses are apparently operating without a clinical laboratory license in California. And they are scaring a lot of people to death.”--Forbes Presentation by Ronald W. Brown, Esq.
Genetic Testing Legislation : There Are A Number of State Proposals  G.I.N.A. sets a floor, not a ceiling.   States can go beyond G.I.N.A ., and some states are proposing legislation doing just that. Presentation by Ronald W. Brown, Esq.
The Legislative Landscape:Proposed Laws--Massachusetts  The Massachusetts Genetic Bill of Rights, (“MAGBR”)introduced on 1/21/11 seeks “to place genetic information on a par with medical records”   MAGBR declares GI “to be the exclusive property of the individual from whom the information was obtained” and prohibits use of GI for marketing or determining creditworthiness.” Presentation by Ronald W. Brown, Esq.
The Legislative Landscape: Proposed Laws--California SB 559 seeks to “expand the bases upon which discrimination is prohibited” under California law to include genetic information.  Provides that California has a “compelling public interest in” both “realizing the medical promise of genetics” and “relieving the fear of discrimination and in prohibiting its actual practice.” Would prohibit discrimination based on genetic information “in the areas of housing, employment, education, public accommodations, health insurance coverage, life insurance coverage, mortgage lending and elections,”
The Growth of Genetic Testing and the Direct To Consumer Market In 1995, only about 300genetic tests were available. Presentation by Ronald W. Brown, Esq. ,[object Object],[object Object]
Genetic Testing and the Direct To Consumer Market Today Direct-to-consumer (DTC) genetic tests are available from retailers and the Internet.  DTC is rapidly expanding market. There are now some 1,300 things you can be genetically tested for – including a genetic susceptibility to cystic fibrosis, muscular dystrophy, hemophilia, Huntington's chorea, sickle cell disease, multiple sclerosis, Cohn's disease, breast cancer, diabetes, heart disease and Alzheimer's. Presentation by Ronald W. Brown, Esq.
Presentation by Ronald W. Brown, Esq.
The Food and Drug Administration In March 2011, the FDA’s Molecular and Clinical Genetics Advisory Panel recommended that “Certain types of genetic tests that are available for at-home use without a prescription should not be used without the involvement of a physician or genetic specialist . The panel wasn’t clear on whether that would mean a physician would have to order the test, or if a physician would have to interpret the test, or both. That will ultimately be up to the FDA to decide.” http://abcnews.go.com March 12,  2011. Presentation by Ronald W. Brown, Esq.
Three Upshots from the Growth in Genetic Testing in the DTC Market #1.	 A lot more information is going to be available to users of the tests. Presentation by Ronald W. Brown, Esq.
Upshot from the Growth in Genetic Testing in the DTC Market #2.	The meaning of DTC genetic test results may be misinterpreted. (False Negatives and False Positives)  Presentation by Ronald W. Brown, Esq.
Upshot from the Growth in Genetic Testing in the DTC Market #3. Users of the test may tell someone their test results  at work. That information could be overheard,  and misused. Presentation by Ronald W. Brown, Esq.
G.I.N.A. IN THE WORKPLACE: CASE SCENARIO  Q1. Can Carol be fired or denied a promotion due to her risk of Huntington’s disease? Q2. If Carol needs to take a leave under FMLA to care for her mom, can the employer use the information on the forms to discriminate against Carol?” Presentation by Ronald W. Brown, Esq.
Answers To The Case Study No, Carol can not be fired or denied a promotion due to her risk of Huntington’s disease. No, the employer can not use information on a FMLA form to discrimination against  Carol. Case and answers from the Genetics and Public Policy Center website Presentation by Ronald W. Brown, Esq.
Answers To The Case Study “GINA indicates when an employer can legally have genetic information about an employee. Two examples: (1) An employer accidentally becomes aware (overhearing a conversation); (2) When an employee provides information for family and medical leave.” “When an employer has genetic information, the employer can not use it to discriminate against an employee, and the information must be kept in a separate and confidential file.” Case and answers from the Genetics and Public Policy Center website Presentation by Ronald W. Brown, Esq.
FINAL REGULATIONS UNDER G.I.N.A.—THE WATER COOLER EXCEPTION The `water cooler problem' arises when an employer unwittingly receives otherwise prohibited genetic information in the form of family medical history through casual conversations with an employee” or by overhearing conversations among co-workers. Congress did not want casual conversation among co-workers regarding health to trigger federal litigation whenever someone mentioned something that might constitute protected family medical history.  Presentation by Ronald W. Brown, Esq. The Commission's proposed regulation therefore noted that a covered entity “inadvertently acquires family medical history” where a manager or supervisor overhears a conversation among co-workers that includes information about family medical history (e.g., a conversation in which one employee tells another that her father has Alzheimer's disease or  her mother has Huntington’s disease).
THE SAFE HARBOR PROVISION   “The Equal Employment Opportunity Commission  included a safe harbor for information accidently received as part of a request for documentation to support requests for reasonable accommodation or FMLA requests.” Presentation by Ronald W. Brown, Esq.
THE SAFE HARBOR PROVISION  However,  “in order for the safe harbor to apply, requests for information from healthcare providers must clearly warn the healthcare provider that requests for health information should notinclude genetic information. “  Presentation by Ronald W. Brown, Esq.
SAMPLE LANGUAGE A COVERED ENTITY MIGHT USE TO PROVIDE THE NOTICE THAT WOULD BRING IT WITHIN THE SAFE HARBOR ‘‘The Genetic Information Nondiscrimination Act of 2008 (GINA) prohibits employers and other entities covered by GINA Title II from requesting or requiring genetic information of employees or their family members. In order to comply with this law, we are asking that you not provide any genetic information when responding to this request for medical information. ‘Genetic information,’ as defined by GINA, includes an individual’s family medical history, the results of an individual’s or family member’s genetic tests, the fact that an individual or an individual’s family member sought or received genetic services, and genetic information of a fetus carried by an individual or an individual’s family member or an embryo lawfully held by an individual or family member receiving assistive reproductive services.’’ Presentation by Ronald W. Brown, Esq.
EEOC  FINAL REGULATIONS UNDER G.I.N.A. EFFECTIVE JANUARY 10, 2011—”REQUESTING”  INFOMATION An employer who does the following would be in violation of GINA: “conducting an Internet search on an individual in a way that is likely to result in a covered entity obtaining genetic information; actively listening to third-party conversations or searching an individual’s personal effects for the purpose of obtaining genetic information; and making requests for information about an individual’s current health status in a way that is likely to result in a covered entity obtaining genetic information.” Presentation by Ronald W. Brown, Esq.
SIX THINGS EVERY EMPLOYER MUST DO #1.  Understand what G.I.N.A. requires you to do and not  to do. #2.  Map out a compliance strategy engaging key individuals with leadership skills  to serve on a cross-functional compliance team:  Management, Legal, Human Resources, and  EEO-AA. If you have a corporate Medical Department, engage a leader from that group as well. Presentation by Ronald W. Brown, Esq.
SIX THINGS EVERY EMPLOYER MUST DO #3. Update your non-discrimination policies  and procedures to include  G.I.N.A. Presentation by Ronald W. Brown, Esq.
SIX THINGS EVERY EMPLOYER MUST DO #4. Incorporate the safe harbor language into the forms you utilize for requesting business related health information (including ADA accommodation,  FMLA or state equivalent). Presentation by Ronald W. Brown, Esq.
SIX THINGS EVERY EMPLOYER MUST DO #5. Do not discriminate or retaliate against a person on the basis of protected genetic information in any employment context. Presentation by Ronald W. Brown, Esq.
SIX THINGS EVERY EMPLOYER MUST DO #6. Do not request, require, or purchase genetic information about an individual or their family members, for example, a wellness program with a premium discount or waiver if the participant takes a health risk assessment. Presentation by Ronald W. Brown, Esq.
G.I.N.A. AND Corporate Wellness and Disease Management Programs Presentation by Ronald W. Brown, Esq.
G.I.N.A. AND Corporate Wellness and Disease Management Programs This is a potential minefield. However, an employer is allowed to collect genetic information for corporate wellness and disease management programs with three provisos. #1: That employees give “prior, knowing, voluntary, and written consent”. #2: That the employer only receives the genetic information in aggregate form. #3: That the employee does not have to fill out a health risk assessment form in order to get a reward. Presentation by Ronald W. Brown, Esq.
The E.E.O.C.  Most of the GINA complaints received by the Equal Employment Opportunity Commission  involve situations  in which an employer had improperly acquired or  had disclosed genetic information.  Presentation by Ronald W. Brown, Esq.
The Pre-G.I.N.A. Legal Landscape EEOC  v, Burlington Northern Santa Fe (2002 Settlement) (Alleged violation of ADA)  Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260 (9th Cir. 1998
The Current G.I.N.A  Landscape: CHARGES WITH THE E.E.O.C.  IN 2010 Presentation by Ronald W. Brown, Esq.
Fink v MXEnergy Company The first case alleging termination because of genetic information  Fink's attorney, Gary Phelan, of the Stamford- and New York-based law firm Outten & Golden, said Fink is the first person in Connecticut to file a complaint under the new law, known as GINA. Fink filed complaints with both state employment officials and the Equal Employment Opportunity Commission (EEOC). Presentation by Ronald W. Brown, Esq.
Fink v MXEnergy Company The first lawsuitunder the Genetic Information Nondiscrimination Act (GINA) has been filed. (June ,2010) Fink was the public relations director for MXenergy from 2006 until her dismissal in March. Presentation by Ronald W. Brown, Esq.
Fink v MXEnergy Company ,[object Object]
The tests showed all three carried the BRCA2 gene.
That gene predisposed them to developing breast cancer.Presentation by Ronald W. Brown, Esq.
Fink v MXEnergy Company Both of Fink’s sisters developed breast cancer, but survived with treatment. After several biopsies and frightening false alarms, Fink opted for a preventative double mastectomy last year. Feeling comfortable in what she described as a supportive work environment, on her own initiative, she told her bosses at MXenergy about her genetic tests and the surgery. "I'd had great reviews, I had merit increases, I had bonuses. I really felt it was a place where I could be comfortable and confident and be honest with them, and that was a mistake,“ Fink said. Presentation by Ronald W. Brown, Esq.
Fink v MXEnergy Company ,[object Object]
Fink says she started to receive negative performance reviews, which hadn’t been the case in her previous four years with the company. Finally, after she had taken an additional ten days off for a second procedure, she was fired.Fink said "I was a great employee and I did really great work.” "The only thing that changed from the time that I had a great review to when I didn't was my two surgeries."  Presentation by Ronald W. Brown, Esq.
Fink v MXEnergy Company ,[object Object]
GINA, bars discrimination against an employee based on the person’s genetic information and medical history. “Genetic information” is defined under federal law as “information about an individual’s genetic tests, the genetic tests of that individual’s family members, and the manifestation of a disease or disorder in family members of the individual.”Company spokesman Todd Miller said MXenergy “emphatically and categorically” denies the allegations, but has a policy not to discuss personnel matters and will not comment further. Presentation by Ronald W. Brown, Esq.

Weitere ähnliche Inhalte

Was ist angesagt?

GINA - Genetic Information Nondiscrimination Act
GINA - Genetic Information Nondiscrimination ActGINA - Genetic Information Nondiscrimination Act
GINA - Genetic Information Nondiscrimination Actdgevertz
 
Dna fragmentation.Life care centre ,IVF ICSI
Dna fragmentation.Life care centre ,IVF ICSIDna fragmentation.Life care centre ,IVF ICSI
Dna fragmentation.Life care centre ,IVF ICSILifecare Centre
 
Quality in ART by Giles Palmer
Quality in ART by Giles Palmer Quality in ART by Giles Palmer
Quality in ART by Giles Palmer Kosmogonia IVF
 
Tissue engineering artificial skin
Tissue engineering artificial skinTissue engineering artificial skin
Tissue engineering artificial skinKAUSHAL SAHU
 
2d analysis for protein ppt
2d analysis for protein ppt2d analysis for protein ppt
2d analysis for protein pptANSHULKUMAR218
 
Prenatal diagnosis, gene manipulation and their ethical issues
Prenatal diagnosis, gene manipulation and their ethical issuesPrenatal diagnosis, gene manipulation and their ethical issues
Prenatal diagnosis, gene manipulation and their ethical issuesRupa Rupagal
 
Third Party Reproduction
Third Party ReproductionThird Party Reproduction
Third Party ReproductionSujoy Dasgupta
 
How to write bioinformatics software no one will use
How to write bioinformatics software no one will useHow to write bioinformatics software no one will use
How to write bioinformatics software no one will useTorsten Seemann
 
Preimplantation genetic testinng
Preimplantation genetic testinngPreimplantation genetic testinng
Preimplantation genetic testinngOsama Abdalmageed
 
Protein structural analysis
Protein structural analysisProtein structural analysis
Protein structural analysiskhansaasad
 
MALDI-TOF: Pricinple and Its Application in Biochemistry and Biotechnology
MALDI-TOF: Pricinple  and Its Application in Biochemistry and BiotechnologyMALDI-TOF: Pricinple  and Its Application in Biochemistry and Biotechnology
MALDI-TOF: Pricinple and Its Application in Biochemistry and BiotechnologyDevakumar Jain
 
PICSI IVF Physiological intracytoplasmic sperm injection
PICSI IVF Physiological intracytoplasmic sperm injection PICSI IVF Physiological intracytoplasmic sperm injection
PICSI IVF Physiological intracytoplasmic sperm injection parth4444
 
Single nucleotide polymorphism
Single nucleotide polymorphismSingle nucleotide polymorphism
Single nucleotide polymorphismSimon Silvan
 
Pulse Field Gel Electrophoresis (PFGE)
Pulse Field Gel Electrophoresis (PFGE)Pulse Field Gel Electrophoresis (PFGE)
Pulse Field Gel Electrophoresis (PFGE)Pranali Marbade
 
Zinc Oxide Nano Structures
Zinc Oxide Nano StructuresZinc Oxide Nano Structures
Zinc Oxide Nano StructuresDeepanshu Bhatia
 

Was ist angesagt? (20)

GINA - Genetic Information Nondiscrimination Act
GINA - Genetic Information Nondiscrimination ActGINA - Genetic Information Nondiscrimination Act
GINA - Genetic Information Nondiscrimination Act
 
Dna fragmentation.Life care centre ,IVF ICSI
Dna fragmentation.Life care centre ,IVF ICSIDna fragmentation.Life care centre ,IVF ICSI
Dna fragmentation.Life care centre ,IVF ICSI
 
Quality in ART by Giles Palmer
Quality in ART by Giles Palmer Quality in ART by Giles Palmer
Quality in ART by Giles Palmer
 
Tissue engineering artificial skin
Tissue engineering artificial skinTissue engineering artificial skin
Tissue engineering artificial skin
 
2d analysis for protein ppt
2d analysis for protein ppt2d analysis for protein ppt
2d analysis for protein ppt
 
Prenatal diagnosis, gene manipulation and their ethical issues
Prenatal diagnosis, gene manipulation and their ethical issuesPrenatal diagnosis, gene manipulation and their ethical issues
Prenatal diagnosis, gene manipulation and their ethical issues
 
Third Party Reproduction
Third Party ReproductionThird Party Reproduction
Third Party Reproduction
 
Pradeep.ii
Pradeep.iiPradeep.ii
Pradeep.ii
 
How to write bioinformatics software no one will use
How to write bioinformatics software no one will useHow to write bioinformatics software no one will use
How to write bioinformatics software no one will use
 
Embryo culture
Embryo cultureEmbryo culture
Embryo culture
 
Preimplantation genetic testinng
Preimplantation genetic testinngPreimplantation genetic testinng
Preimplantation genetic testinng
 
Antigen antibody
Antigen antibodyAntigen antibody
Antigen antibody
 
Protein structural analysis
Protein structural analysisProtein structural analysis
Protein structural analysis
 
MALDI-TOF: Pricinple and Its Application in Biochemistry and Biotechnology
MALDI-TOF: Pricinple  and Its Application in Biochemistry and BiotechnologyMALDI-TOF: Pricinple  and Its Application in Biochemistry and Biotechnology
MALDI-TOF: Pricinple and Its Application in Biochemistry and Biotechnology
 
PICSI IVF Physiological intracytoplasmic sperm injection
PICSI IVF Physiological intracytoplasmic sperm injection PICSI IVF Physiological intracytoplasmic sperm injection
PICSI IVF Physiological intracytoplasmic sperm injection
 
Single nucleotide polymorphism
Single nucleotide polymorphismSingle nucleotide polymorphism
Single nucleotide polymorphism
 
Pitfalls of PGTa
Pitfalls of PGTaPitfalls of PGTa
Pitfalls of PGTa
 
Pulse Field Gel Electrophoresis (PFGE)
Pulse Field Gel Electrophoresis (PFGE)Pulse Field Gel Electrophoresis (PFGE)
Pulse Field Gel Electrophoresis (PFGE)
 
Protein database
Protein databaseProtein database
Protein database
 
Zinc Oxide Nano Structures
Zinc Oxide Nano StructuresZinc Oxide Nano Structures
Zinc Oxide Nano Structures
 

Ähnlich wie Overview of the Genetic Information Nondiscrimination Act

April 2011 What Every Business Executive Needs To Know About G.I.N.A.
April 2011  What Every Business Executive Needs To Know About G.I.N.A.April 2011  What Every Business Executive Needs To Know About G.I.N.A.
April 2011 What Every Business Executive Needs To Know About G.I.N.A.RBCG1
 
Eight Highlights Of G.I.N.A. For Linked In
Eight Highlights Of G.I.N.A. For Linked InEight Highlights Of G.I.N.A. For Linked In
Eight Highlights Of G.I.N.A. For Linked InRBCG1
 
Record peeking
Record peekingRecord peeking
Record peekingpurc1968
 
Racial Profiling and Its Effects
Racial Profiling and Its EffectsRacial Profiling and Its Effects
Racial Profiling and Its EffectsChey Bradley
 
Blume 2010 AAIDD Atkins MR/ID Death Penalty Symposium presentation
Blume 2010 AAIDD Atkins MR/ID Death Penalty Symposium presentationBlume 2010 AAIDD Atkins MR/ID Death Penalty Symposium presentation
Blume 2010 AAIDD Atkins MR/ID Death Penalty Symposium presentationKevin McGrew
 
2bvaltierra Operons Students
2bvaltierra Operons Students2bvaltierra Operons Students
2bvaltierra Operons Studentsrjnorton84
 
Transgender employees
Transgender employeesTransgender employees
Transgender employeesSaman Sara
 
feminist praxis project.pdf
feminist praxis project.pdffeminist praxis project.pdf
feminist praxis project.pdfMiaBylykbashi
 
IB Theory of Knowledge EA: Disagreement Between Experts in a Discipline
IB Theory of Knowledge EA: Disagreement Between Experts in a DisciplineIB Theory of Knowledge EA: Disagreement Between Experts in a Discipline
IB Theory of Knowledge EA: Disagreement Between Experts in a DisciplineLaurel Ayuyao
 
Unit 9 project elizabeth hall assessing competency
Unit 9 project elizabeth hall assessing competencyUnit 9 project elizabeth hall assessing competency
Unit 9 project elizabeth hall assessing competencyElizabeth Hall
 
Consumer Behavior Towards Organ Donation
Consumer Behavior Towards Organ DonationConsumer Behavior Towards Organ Donation
Consumer Behavior Towards Organ DonationSkalla Marketing
 
Study Carl Sagan's Recently Uncovered Characters Concerning The War On Drugs
Study Carl Sagan's Recently Uncovered Characters Concerning The War On Drugs
Study Carl Sagan's Recently Uncovered Characters Concerning The War On Drugs
Study Carl Sagan's Recently Uncovered Characters Concerning The War On Drugs earsplittingfor27
 
TOPICSEnvironmentAnimal WelfareClimate ChangeAir QualityEndangered .docx
TOPICSEnvironmentAnimal WelfareClimate ChangeAir QualityEndangered .docxTOPICSEnvironmentAnimal WelfareClimate ChangeAir QualityEndangered .docx
TOPICSEnvironmentAnimal WelfareClimate ChangeAir QualityEndangered .docxjolleybendicty
 

Ähnlich wie Overview of the Genetic Information Nondiscrimination Act (20)

April 2011 What Every Business Executive Needs To Know About G.I.N.A.
April 2011  What Every Business Executive Needs To Know About G.I.N.A.April 2011  What Every Business Executive Needs To Know About G.I.N.A.
April 2011 What Every Business Executive Needs To Know About G.I.N.A.
 
Eight Highlights Of G.I.N.A. For Linked In
Eight Highlights Of G.I.N.A. For Linked InEight Highlights Of G.I.N.A. For Linked In
Eight Highlights Of G.I.N.A. For Linked In
 
Record peeking
Record peekingRecord peeking
Record peeking
 
Genetic privacy
Genetic privacyGenetic privacy
Genetic privacy
 
Mandater reporter
Mandater reporterMandater reporter
Mandater reporter
 
Racial Profiling and Its Effects
Racial Profiling and Its EffectsRacial Profiling and Its Effects
Racial Profiling and Its Effects
 
Dov Fox, "Birth Rights & Wrongs: How Medicine and Technology Are Remaking Rep...
Dov Fox, "Birth Rights & Wrongs: How Medicine and Technology Are Remaking Rep...Dov Fox, "Birth Rights & Wrongs: How Medicine and Technology Are Remaking Rep...
Dov Fox, "Birth Rights & Wrongs: How Medicine and Technology Are Remaking Rep...
 
Blume 2010 AAIDD Atkins MR/ID Death Penalty Symposium presentation
Blume 2010 AAIDD Atkins MR/ID Death Penalty Symposium presentationBlume 2010 AAIDD Atkins MR/ID Death Penalty Symposium presentation
Blume 2010 AAIDD Atkins MR/ID Death Penalty Symposium presentation
 
Pub132
Pub132Pub132
Pub132
 
2bvaltierra Operons Students
2bvaltierra Operons Students2bvaltierra Operons Students
2bvaltierra Operons Students
 
Transgender employees
Transgender employeesTransgender employees
Transgender employees
 
feminist praxis project.pdf
feminist praxis project.pdffeminist praxis project.pdf
feminist praxis project.pdf
 
IB Theory of Knowledge EA: Disagreement Between Experts in a Discipline
IB Theory of Knowledge EA: Disagreement Between Experts in a DisciplineIB Theory of Knowledge EA: Disagreement Between Experts in a Discipline
IB Theory of Knowledge EA: Disagreement Between Experts in a Discipline
 
Unit 9 project elizabeth hall assessing competency
Unit 9 project elizabeth hall assessing competencyUnit 9 project elizabeth hall assessing competency
Unit 9 project elizabeth hall assessing competency
 
Consumer Behavior Towards Organ Donation
Consumer Behavior Towards Organ DonationConsumer Behavior Towards Organ Donation
Consumer Behavior Towards Organ Donation
 
Human cloning (2)
Human cloning (2)Human cloning (2)
Human cloning (2)
 
Study Carl Sagan's Recently Uncovered Characters Concerning The War On Drugs
Study Carl Sagan's Recently Uncovered Characters Concerning The War On Drugs
Study Carl Sagan's Recently Uncovered Characters Concerning The War On Drugs
Study Carl Sagan's Recently Uncovered Characters Concerning The War On Drugs
 
TOPICSEnvironmentAnimal WelfareClimate ChangeAir QualityEndangered .docx
TOPICSEnvironmentAnimal WelfareClimate ChangeAir QualityEndangered .docxTOPICSEnvironmentAnimal WelfareClimate ChangeAir QualityEndangered .docx
TOPICSEnvironmentAnimal WelfareClimate ChangeAir QualityEndangered .docx
 
JUNE 9, 2008 PRESS RELEASE
JUNE 9, 2008 PRESS RELEASEJUNE 9, 2008 PRESS RELEASE
JUNE 9, 2008 PRESS RELEASE
 
Abortion update
Abortion updateAbortion update
Abortion update
 

Mehr von RBCG1

Part Iib Some Thoughts About Mediation
Part Iib Some Thoughts About MediationPart Iib Some Thoughts About Mediation
Part Iib Some Thoughts About MediationRBCG1
 
Part Iia Some Thoughts About Mediation
Part Iia Some Thoughts About MediationPart Iia Some Thoughts About Mediation
Part Iia Some Thoughts About MediationRBCG1
 
Part I Ronald W Brown Some Thoughts About Mediation October 2011
Part I Ronald W Brown Some Thoughts About Mediation October 2011Part I Ronald W Brown Some Thoughts About Mediation October 2011
Part I Ronald W Brown Some Thoughts About Mediation October 2011RBCG1
 
April 2011 Part Ii What Every Executive Should Know About Dispute Resolution
April 2011  Part Ii  What Every Executive Should Know About Dispute ResolutionApril 2011  Part Ii  What Every Executive Should Know About Dispute Resolution
April 2011 Part Ii What Every Executive Should Know About Dispute ResolutionRBCG1
 
April 2011 Part I What Every Executive Should Know About Dispute Resolution
April 2011 Part I  What Every Executive Should Know About Dispute ResolutionApril 2011 Part I  What Every Executive Should Know About Dispute Resolution
April 2011 Part I What Every Executive Should Know About Dispute ResolutionRBCG1
 
Anatomy Of A Bodyof Ethics Complianceand Requirements 2010[1]
Anatomy Of A Bodyof Ethics Complianceand Requirements 2010[1]Anatomy Of A Bodyof Ethics Complianceand Requirements 2010[1]
Anatomy Of A Bodyof Ethics Complianceand Requirements 2010[1]RBCG1
 
Rwb October 27 Part Ii What Every Business Executive Needs To Know About Stra...
Rwb October 27 Part Ii What Every Business Executive Needs To Know About Stra...Rwb October 27 Part Ii What Every Business Executive Needs To Know About Stra...
Rwb October 27 Part Ii What Every Business Executive Needs To Know About Stra...RBCG1
 
Anatomy Of Amou 16 20
Anatomy Of Amou 16 20Anatomy Of Amou 16 20
Anatomy Of Amou 16 20RBCG1
 
Anatomy Of Amou 6 10
Anatomy Of Amou 6 10Anatomy Of Amou 6 10
Anatomy Of Amou 6 10RBCG1
 
Joint Venturing
Joint VenturingJoint Venturing
Joint VenturingRBCG1
 
Meeting The Challenge Of Changing Times
Meeting The Challenge Of Changing TimesMeeting The Challenge Of Changing Times
Meeting The Challenge Of Changing TimesRBCG1
 
Part Ii What Every Executive Should Know About Dispute Resolution
Part Ii  What Every Executive Should Know About Dispute ResolutionPart Ii  What Every Executive Should Know About Dispute Resolution
Part Ii What Every Executive Should Know About Dispute ResolutionRBCG1
 
Part I What Every Executive Should Know About Dispute Resolution
Part I  What Every Executive Should Know About Dispute ResolutionPart I  What Every Executive Should Know About Dispute Resolution
Part I What Every Executive Should Know About Dispute ResolutionRBCG1
 
Part Ii What Every Executive Should Know About Dispute Resolution
Part Ii  What Every Executive Should Know About Dispute ResolutionPart Ii  What Every Executive Should Know About Dispute Resolution
Part Ii What Every Executive Should Know About Dispute ResolutionRBCG1
 
Part I What Every Executive Should Know About Dispute Resolution
Part I  What Every Executive Should Know About Dispute ResolutionPart I  What Every Executive Should Know About Dispute Resolution
Part I What Every Executive Should Know About Dispute ResolutionRBCG1
 
Joint Venturing
Joint VenturingJoint Venturing
Joint VenturingRBCG1
 

Mehr von RBCG1 (16)

Part Iib Some Thoughts About Mediation
Part Iib Some Thoughts About MediationPart Iib Some Thoughts About Mediation
Part Iib Some Thoughts About Mediation
 
Part Iia Some Thoughts About Mediation
Part Iia Some Thoughts About MediationPart Iia Some Thoughts About Mediation
Part Iia Some Thoughts About Mediation
 
Part I Ronald W Brown Some Thoughts About Mediation October 2011
Part I Ronald W Brown Some Thoughts About Mediation October 2011Part I Ronald W Brown Some Thoughts About Mediation October 2011
Part I Ronald W Brown Some Thoughts About Mediation October 2011
 
April 2011 Part Ii What Every Executive Should Know About Dispute Resolution
April 2011  Part Ii  What Every Executive Should Know About Dispute ResolutionApril 2011  Part Ii  What Every Executive Should Know About Dispute Resolution
April 2011 Part Ii What Every Executive Should Know About Dispute Resolution
 
April 2011 Part I What Every Executive Should Know About Dispute Resolution
April 2011 Part I  What Every Executive Should Know About Dispute ResolutionApril 2011 Part I  What Every Executive Should Know About Dispute Resolution
April 2011 Part I What Every Executive Should Know About Dispute Resolution
 
Anatomy Of A Bodyof Ethics Complianceand Requirements 2010[1]
Anatomy Of A Bodyof Ethics Complianceand Requirements 2010[1]Anatomy Of A Bodyof Ethics Complianceand Requirements 2010[1]
Anatomy Of A Bodyof Ethics Complianceand Requirements 2010[1]
 
Rwb October 27 Part Ii What Every Business Executive Needs To Know About Stra...
Rwb October 27 Part Ii What Every Business Executive Needs To Know About Stra...Rwb October 27 Part Ii What Every Business Executive Needs To Know About Stra...
Rwb October 27 Part Ii What Every Business Executive Needs To Know About Stra...
 
Anatomy Of Amou 16 20
Anatomy Of Amou 16 20Anatomy Of Amou 16 20
Anatomy Of Amou 16 20
 
Anatomy Of Amou 6 10
Anatomy Of Amou 6 10Anatomy Of Amou 6 10
Anatomy Of Amou 6 10
 
Joint Venturing
Joint VenturingJoint Venturing
Joint Venturing
 
Meeting The Challenge Of Changing Times
Meeting The Challenge Of Changing TimesMeeting The Challenge Of Changing Times
Meeting The Challenge Of Changing Times
 
Part Ii What Every Executive Should Know About Dispute Resolution
Part Ii  What Every Executive Should Know About Dispute ResolutionPart Ii  What Every Executive Should Know About Dispute Resolution
Part Ii What Every Executive Should Know About Dispute Resolution
 
Part I What Every Executive Should Know About Dispute Resolution
Part I  What Every Executive Should Know About Dispute ResolutionPart I  What Every Executive Should Know About Dispute Resolution
Part I What Every Executive Should Know About Dispute Resolution
 
Part Ii What Every Executive Should Know About Dispute Resolution
Part Ii  What Every Executive Should Know About Dispute ResolutionPart Ii  What Every Executive Should Know About Dispute Resolution
Part Ii What Every Executive Should Know About Dispute Resolution
 
Part I What Every Executive Should Know About Dispute Resolution
Part I  What Every Executive Should Know About Dispute ResolutionPart I  What Every Executive Should Know About Dispute Resolution
Part I What Every Executive Should Know About Dispute Resolution
 
Joint Venturing
Joint VenturingJoint Venturing
Joint Venturing
 

Kürzlich hochgeladen

How to write a Business Continuity Plan
How to write a Business Continuity PlanHow to write a Business Continuity Plan
How to write a Business Continuity PlanDatabarracks
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfAlex Barbosa Coqueiro
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
 
From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .Alan Dix
 
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DayH2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DaySri Ambati
 
Powerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time ClashPowerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time Clashcharlottematthew16
 
Search Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfSearch Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfRankYa
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii SoldatenkoFwdays
 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brandgvaughan
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsMiki Katsuragi
 
DevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenDevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenHervé Boutemy
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsSergiu Bodiu
 
Artificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxArtificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxhariprasad279825
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr BaganFwdays
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 

Kürzlich hochgeladen (20)

How to write a Business Continuity Plan
How to write a Business Continuity PlanHow to write a Business Continuity Plan
How to write a Business Continuity Plan
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdf
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
 
From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .
 
DMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special EditionDMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special Edition
 
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DayH2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
 
Powerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time ClashPowerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time Clash
 
Search Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfSearch Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdf
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko
 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brand
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine Tuning
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering Tips
 
DevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenDevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache Maven
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platforms
 
Artificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxArtificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptx
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 

Overview of the Genetic Information Nondiscrimination Act

  • 1. AMERICAN ASSOCIATION FOR AFFIRMATIVE ACTION In partnership with New Jersey Affirmative Action Officers’ Council (NJAAOC) Access, Equity and Diversity Summit The Atlantic City Convention Center A PRESENTATION BY RONALD W. BROWN, ESQ.
  • 2. Presentation by Ronald W. Brown, Esq. Recent Legal Developments: A Presentation on the Genetic Information Non-Discrimination Act
  • 3. AN OVERVIEW OF THE GENETIC INFORMATION NONDISCRIMINATION ACT Presentation by Ronald W. Brown, Esq.
  • 4. G.I.N.A. IN THE WORKPLACE: CASE SCENARIO While on break at a work water cooler, Carol tells her coworker Bob about the battle her mom is having with Huntington’s disease. Carol tells Bob that “Huntington’s disease is a progressive, degenerative disease” that causes certain nerve cells in the brain to waste away. As a result,” a person may experience uncontrolled movements, emotional disturbances and mental deterioration.” Carol tells Bob that she fears she is at risk for this genetic disease and that she periodically uses in the rest room at work, a Direct To Consumer testing kit she purchased over the Internet. Presentation by Ronald W. Brown, Esq.
  • 5. G.I.N.A. IN THE WORKPLACE: CASE SCENARIO continued Carol’s supervisor, Ted, walks by and overhears the conversation. Carol becomes concerned that she may be treated differently by Ted or fired due to her risk for developing HD. Carol starts reading about the disease during her lunch time at work. Presentation by Ronald W. Brown, Esq.
  • 6. G.I.N.A. IN THE WORKPLACE: CASE SCENARIO continued Presentation by Ronald W. Brown, Esq. Carol starts using “sick days” in order to take her mom to the doctor. At her annual performance review, Ted gives Carol numbers that are so low they will preclude her qualifying for the promotion she wanted and would otherwise get. Carol had always had stellar reviews in the past. When Carol asks Ted about the numbers, Ted tells her “Carol, you are no longer a team player. Whenever I really need you here working you are out sick.” He also says, “Carol, you are not as mentally sharp as you used to be. You seem to be emotionally disturbed and deteriorating mentally. What’s wrong with you?”
  • 7. G.I.N.A. IN THE WORKPLACE: CASE SCENARIO #1 continued Furious, Carol leaves the performance review, goes back to her cubicle. Saying “He does not know who he is messing with!”, she proceeds to put up two posters. One reads” Power to the People”. Every time she passes it she starts chanting: “United, the people, can never be defeated!” The other is A Genetic Bill of Rights poster that reads “All People Have The Right To Be Free From Genetic Discrimination.” Presentation by Ronald W. Brown, Esq.
  • 8. G.I.N.A. IN THE WORKPLACE: CASE SCENARIO #1 continued Carol also starts coming to work wearing Jeans for Genes with a button that reads “How my jeans fit or my genes behave is none of this company’s business!” Presentation by Ronald W. Brown, Esq. Carol comes to you as EEO-AA officer to file a G.I.N.A. claim. What do you do?
  • 9. Four Answers to the Question: What Do You Do? 1. If you need it, ask for help from functional “superheroes” with SME, e.g. legal, medical, etc. . 2. Familiarize yourself with what G.I.N.A. is, what it covers, and what it does not cover. 3. Determine if you need to adapt your normal investigative procedures to fit G.I.N.A. Presentation by Ronald W. Brown, Esq. 4. Focus on answering at least the following two important questions.
  • 10. G.I.N.A. IN THE WORKPLACE: CASE SCENARIO Q1. Can Carol be fired or denied a promotion due to her risk of Huntington’s disease? Q2. If Carol needs to take a leave under FMLA to care for her mom, can the employer use the information on the forms to discriminate against Carol?” Presentation by Ronald W. Brown, Esq.
  • 11. G.I.N.A. Title I Title II Prohibits discrimination in health coverage based on genetic information. Prohibits discrimination in employment based on genetic information. Presentation by Ronald W. Brown, Esq.
  • 12.
  • 13. The Use and Misuse of Genes and Genetic Information Have Popped Up In A Variety of Older Sci-Fi and Film Contexts Presentation by Ronald W. Brown, Esq.
  • 14. Genetic Testing Issues Have Popped Up In A More Recent Film Context “Officially they are called ‘In-valids’…They are the ‘healthy ill’. They don’t actually have anything yet—they may never have. But since few of the pre-conditions can be cured or reversed, it is easier to treat them as if they were already sick.” Pre-G.I.N.A.? Presentation by Ronald W. Brown, Esq.
  • 15. Genetic Testing Issues Have Popped Up In A Variety of Contexts: Major League Baseball In July, 2009, Major League Baseball used DNA testing to determine if Miguel Sano, a prospect from the Dominican Republic, was really 16 years old. MLB said that testing in the Dominican Republic is used“ in very rare instances and only on a consensual basis to deal with the identity fraud problem that the league faces in that country.” The statement added that the results of the tests were not used for any other purpose. Presentation by Ronald W. Brown, Esq. Also in July 2009, the New York Yankees voided the signing of an amateur from the Dominican Republic after a DNA test conducted by Major League Baseball’s department of investigations showed that the player had misrepresented his identity.
  • 16. G.I.N.A. In A Nutshell The law forbids discrimination on the basis of genetic information when it comes to any aspect of employment, including hiring, firing, pay, job assignments, promotions, layoffs, training, fringe benefits, or any other term or condition of employment. Genetic information includes information about an individual’s genetic tests and the genetic tests of an individual’s family members, as well as information about any disease, disorder, or condition of an individual’s family members (i.e. an individual’s family medical history). “An employer may never use genetic information to make an employment decision because genetic information doesn’t tell the employer anything about someone’s current ability to work.” Presentation by Ronald W. Brown, Esq.
  • 17. G.I.N.A In A Nutshell Title II of G.I.N.A. prohibits use of genetic information in the employment context, restricts employers and other entities covered by Title II from requesting, requiring, or purchasing genetic information, and strictly limits such entities from disclosing genetic information. Presentation by Ronald W. Brown, Esq.
  • 18. G.I.N.A. IN A Nutshell—What Is and What Is Not A Genetic Test? “Genetic test” refers to “analysis of human DNA, RNA, chromosomes, proteins, or metabolites that detects genotypes, mutations, or chromosomal changes.” “Tests to determine whether an individual carries the genetic variant evidencing a predisposition to breast cancer, colorectal cancer are genetic tests.” “Tests for infectious and communicable diseases that may be transmitted through food handling, complete blood counts, cholesterol tests, and liver-function tests are not genetic tests.” Presentation by Ronald W. Brown, Esq.
  • 19. G.I.N.A. IN A NUTSHELL Information about race and ethnicity that is not derived from a genetic test is not “genetic information” for purposes of GINA. Presentation by Ronald W. Brown, Esq.
  • 20. Gene Testing and State Intervention Overall, 24 states prohibit or limit so-called direct access testing without a doctor or other medical professional’s involvement”—Forbes Presentation by Ronald W. Brown, Esq.
  • 21. Gene Testing and State Intervention “New York State’s Department of Health sent letters raising the specter of fines and jail time to six online gene-testing firms that offer consumers the ability to pear into their genome to assess the risk of getting disease. Often, it turns out, the services offering these DNA deep-dives are doing so without the involvement of a doctor. That puts them on the wrong side of the law.”--Forbes Presentation by Ronald W. Brown, Esq.
  • 22. Gene Testing and State Intervention “California’s Department of Public Health sent cease-and-desist letters to 13 companies that offer gene testing to consumers via the Web. California law requires that a licensed physician order any lab tests, including genetic tests, All lab tests must also be validated for accuracy and medical utility. These businesses are apparently operating without a clinical laboratory license in California. And they are scaring a lot of people to death.”--Forbes Presentation by Ronald W. Brown, Esq.
  • 23. Genetic Testing Legislation : There Are A Number of State Proposals G.I.N.A. sets a floor, not a ceiling. States can go beyond G.I.N.A ., and some states are proposing legislation doing just that. Presentation by Ronald W. Brown, Esq.
  • 24. The Legislative Landscape:Proposed Laws--Massachusetts The Massachusetts Genetic Bill of Rights, (“MAGBR”)introduced on 1/21/11 seeks “to place genetic information on a par with medical records” MAGBR declares GI “to be the exclusive property of the individual from whom the information was obtained” and prohibits use of GI for marketing or determining creditworthiness.” Presentation by Ronald W. Brown, Esq.
  • 25. The Legislative Landscape: Proposed Laws--California SB 559 seeks to “expand the bases upon which discrimination is prohibited” under California law to include genetic information. Provides that California has a “compelling public interest in” both “realizing the medical promise of genetics” and “relieving the fear of discrimination and in prohibiting its actual practice.” Would prohibit discrimination based on genetic information “in the areas of housing, employment, education, public accommodations, health insurance coverage, life insurance coverage, mortgage lending and elections,”
  • 26.
  • 27. Genetic Testing and the Direct To Consumer Market Today Direct-to-consumer (DTC) genetic tests are available from retailers and the Internet. DTC is rapidly expanding market. There are now some 1,300 things you can be genetically tested for – including a genetic susceptibility to cystic fibrosis, muscular dystrophy, hemophilia, Huntington's chorea, sickle cell disease, multiple sclerosis, Cohn's disease, breast cancer, diabetes, heart disease and Alzheimer's. Presentation by Ronald W. Brown, Esq.
  • 28. Presentation by Ronald W. Brown, Esq.
  • 29. The Food and Drug Administration In March 2011, the FDA’s Molecular and Clinical Genetics Advisory Panel recommended that “Certain types of genetic tests that are available for at-home use without a prescription should not be used without the involvement of a physician or genetic specialist . The panel wasn’t clear on whether that would mean a physician would have to order the test, or if a physician would have to interpret the test, or both. That will ultimately be up to the FDA to decide.” http://abcnews.go.com March 12, 2011. Presentation by Ronald W. Brown, Esq.
  • 30. Three Upshots from the Growth in Genetic Testing in the DTC Market #1. A lot more information is going to be available to users of the tests. Presentation by Ronald W. Brown, Esq.
  • 31. Upshot from the Growth in Genetic Testing in the DTC Market #2. The meaning of DTC genetic test results may be misinterpreted. (False Negatives and False Positives) Presentation by Ronald W. Brown, Esq.
  • 32. Upshot from the Growth in Genetic Testing in the DTC Market #3. Users of the test may tell someone their test results at work. That information could be overheard, and misused. Presentation by Ronald W. Brown, Esq.
  • 33. G.I.N.A. IN THE WORKPLACE: CASE SCENARIO Q1. Can Carol be fired or denied a promotion due to her risk of Huntington’s disease? Q2. If Carol needs to take a leave under FMLA to care for her mom, can the employer use the information on the forms to discriminate against Carol?” Presentation by Ronald W. Brown, Esq.
  • 34. Answers To The Case Study No, Carol can not be fired or denied a promotion due to her risk of Huntington’s disease. No, the employer can not use information on a FMLA form to discrimination against Carol. Case and answers from the Genetics and Public Policy Center website Presentation by Ronald W. Brown, Esq.
  • 35. Answers To The Case Study “GINA indicates when an employer can legally have genetic information about an employee. Two examples: (1) An employer accidentally becomes aware (overhearing a conversation); (2) When an employee provides information for family and medical leave.” “When an employer has genetic information, the employer can not use it to discriminate against an employee, and the information must be kept in a separate and confidential file.” Case and answers from the Genetics and Public Policy Center website Presentation by Ronald W. Brown, Esq.
  • 36. FINAL REGULATIONS UNDER G.I.N.A.—THE WATER COOLER EXCEPTION The `water cooler problem' arises when an employer unwittingly receives otherwise prohibited genetic information in the form of family medical history through casual conversations with an employee” or by overhearing conversations among co-workers. Congress did not want casual conversation among co-workers regarding health to trigger federal litigation whenever someone mentioned something that might constitute protected family medical history. Presentation by Ronald W. Brown, Esq. The Commission's proposed regulation therefore noted that a covered entity “inadvertently acquires family medical history” where a manager or supervisor overhears a conversation among co-workers that includes information about family medical history (e.g., a conversation in which one employee tells another that her father has Alzheimer's disease or her mother has Huntington’s disease).
  • 37. THE SAFE HARBOR PROVISION “The Equal Employment Opportunity Commission included a safe harbor for information accidently received as part of a request for documentation to support requests for reasonable accommodation or FMLA requests.” Presentation by Ronald W. Brown, Esq.
  • 38. THE SAFE HARBOR PROVISION However, “in order for the safe harbor to apply, requests for information from healthcare providers must clearly warn the healthcare provider that requests for health information should notinclude genetic information. “ Presentation by Ronald W. Brown, Esq.
  • 39. SAMPLE LANGUAGE A COVERED ENTITY MIGHT USE TO PROVIDE THE NOTICE THAT WOULD BRING IT WITHIN THE SAFE HARBOR ‘‘The Genetic Information Nondiscrimination Act of 2008 (GINA) prohibits employers and other entities covered by GINA Title II from requesting or requiring genetic information of employees or their family members. In order to comply with this law, we are asking that you not provide any genetic information when responding to this request for medical information. ‘Genetic information,’ as defined by GINA, includes an individual’s family medical history, the results of an individual’s or family member’s genetic tests, the fact that an individual or an individual’s family member sought or received genetic services, and genetic information of a fetus carried by an individual or an individual’s family member or an embryo lawfully held by an individual or family member receiving assistive reproductive services.’’ Presentation by Ronald W. Brown, Esq.
  • 40. EEOC FINAL REGULATIONS UNDER G.I.N.A. EFFECTIVE JANUARY 10, 2011—”REQUESTING” INFOMATION An employer who does the following would be in violation of GINA: “conducting an Internet search on an individual in a way that is likely to result in a covered entity obtaining genetic information; actively listening to third-party conversations or searching an individual’s personal effects for the purpose of obtaining genetic information; and making requests for information about an individual’s current health status in a way that is likely to result in a covered entity obtaining genetic information.” Presentation by Ronald W. Brown, Esq.
  • 41. SIX THINGS EVERY EMPLOYER MUST DO #1. Understand what G.I.N.A. requires you to do and not to do. #2. Map out a compliance strategy engaging key individuals with leadership skills to serve on a cross-functional compliance team: Management, Legal, Human Resources, and EEO-AA. If you have a corporate Medical Department, engage a leader from that group as well. Presentation by Ronald W. Brown, Esq.
  • 42. SIX THINGS EVERY EMPLOYER MUST DO #3. Update your non-discrimination policies and procedures to include G.I.N.A. Presentation by Ronald W. Brown, Esq.
  • 43. SIX THINGS EVERY EMPLOYER MUST DO #4. Incorporate the safe harbor language into the forms you utilize for requesting business related health information (including ADA accommodation, FMLA or state equivalent). Presentation by Ronald W. Brown, Esq.
  • 44. SIX THINGS EVERY EMPLOYER MUST DO #5. Do not discriminate or retaliate against a person on the basis of protected genetic information in any employment context. Presentation by Ronald W. Brown, Esq.
  • 45. SIX THINGS EVERY EMPLOYER MUST DO #6. Do not request, require, or purchase genetic information about an individual or their family members, for example, a wellness program with a premium discount or waiver if the participant takes a health risk assessment. Presentation by Ronald W. Brown, Esq.
  • 46. G.I.N.A. AND Corporate Wellness and Disease Management Programs Presentation by Ronald W. Brown, Esq.
  • 47. G.I.N.A. AND Corporate Wellness and Disease Management Programs This is a potential minefield. However, an employer is allowed to collect genetic information for corporate wellness and disease management programs with three provisos. #1: That employees give “prior, knowing, voluntary, and written consent”. #2: That the employer only receives the genetic information in aggregate form. #3: That the employee does not have to fill out a health risk assessment form in order to get a reward. Presentation by Ronald W. Brown, Esq.
  • 48. The E.E.O.C. Most of the GINA complaints received by the Equal Employment Opportunity Commission involve situations in which an employer had improperly acquired or had disclosed genetic information. Presentation by Ronald W. Brown, Esq.
  • 49. The Pre-G.I.N.A. Legal Landscape EEOC v, Burlington Northern Santa Fe (2002 Settlement) (Alleged violation of ADA) Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260 (9th Cir. 1998
  • 50. The Current G.I.N.A Landscape: CHARGES WITH THE E.E.O.C. IN 2010 Presentation by Ronald W. Brown, Esq.
  • 51. Fink v MXEnergy Company The first case alleging termination because of genetic information Fink's attorney, Gary Phelan, of the Stamford- and New York-based law firm Outten & Golden, said Fink is the first person in Connecticut to file a complaint under the new law, known as GINA. Fink filed complaints with both state employment officials and the Equal Employment Opportunity Commission (EEOC). Presentation by Ronald W. Brown, Esq.
  • 52. Fink v MXEnergy Company The first lawsuitunder the Genetic Information Nondiscrimination Act (GINA) has been filed. (June ,2010) Fink was the public relations director for MXenergy from 2006 until her dismissal in March. Presentation by Ronald W. Brown, Esq.
  • 53.
  • 54. The tests showed all three carried the BRCA2 gene.
  • 55. That gene predisposed them to developing breast cancer.Presentation by Ronald W. Brown, Esq.
  • 56. Fink v MXEnergy Company Both of Fink’s sisters developed breast cancer, but survived with treatment. After several biopsies and frightening false alarms, Fink opted for a preventative double mastectomy last year. Feeling comfortable in what she described as a supportive work environment, on her own initiative, she told her bosses at MXenergy about her genetic tests and the surgery. "I'd had great reviews, I had merit increases, I had bonuses. I really felt it was a place where I could be comfortable and confident and be honest with them, and that was a mistake,“ Fink said. Presentation by Ronald W. Brown, Esq.
  • 57.
  • 58. Fink says she started to receive negative performance reviews, which hadn’t been the case in her previous four years with the company. Finally, after she had taken an additional ten days off for a second procedure, she was fired.Fink said "I was a great employee and I did really great work.” "The only thing that changed from the time that I had a great review to when I didn't was my two surgeries." Presentation by Ronald W. Brown, Esq.
  • 59.
  • 60. GINA, bars discrimination against an employee based on the person’s genetic information and medical history. “Genetic information” is defined under federal law as “information about an individual’s genetic tests, the genetic tests of that individual’s family members, and the manifestation of a disease or disorder in family members of the individual.”Company spokesman Todd Miller said MXenergy “emphatically and categorically” denies the allegations, but has a policy not to discuss personnel matters and will not comment further. Presentation by Ronald W. Brown, Esq.
  • 61. THREE VIEWS FROM THREE LAWYERS AND A FINAL WORD FROM MRS. FINK 1. “The purpose of GINA is to offer protections from companies trying to purge their workforce of people who drive up health insurance costs, or those who could drive up costs based on test results that show they’re susceptible to certain diseases.” 2. “I can see [litigation] happening with more and more people as genetic testing becomes less costly and more available”. 3. The chairwoman of the board of the national Women’s Law Project says: “Unfortunately, I think in today’s day and age people have started sharing a lot more personal information about themselves, whether it’s in social media or in the workplace. I think it may behoove people to keep some of that information closer to the vest” . Presentation by Ronald W. Brown, Esq.
  • 62. Fink v MXEnergy Company Presentation by Ronald W. Brown, Esq.

Hinweis der Redaktion

  1. My overview is going to start with a scenario that you could be faced with. The scenario ends with a question. My presentation will enable you to answer the question when we come back to the scenario a bit later.
  2. If you are a Star Trek fan, then you know about Ricardo Montalbán portraying Khan Noonien Singh. According to Wikipedia, Khan was a “genetically enhanced superhuman who used his strength and intellect to briefly rule much of Earth in the 1990s. Again, as summarized in Wikipedia, the plot of the Wrath of Khan “ features James T. Kirk (William Shatner) and the crew of the starship USS Enterprise facing off against the genetically-engineered tyrant Khan Noonien Singh (Ricardo Montalbán), a character who first appeared in the 1967 Star Trek television series episode "Space Seed“. “Montalbán said that he believed all good villains do villainous things, but think that they are acting for the "right" reasons; in this way, Khan uses his anger at the death of his wife to justify his pursuit of Kirk.[6] Contrary to speculation that Montalbán used a prosthetic chest, no artificial devices were added to Montalbán's muscular physique.[5] Montalbán enjoyed making the film, so much so that he played the role for much less than was offered him, and counted the role as a career highlight.”
  3. These italicized words reflect a vision of a genetic discriminating future that would give anyone pause, and which G.I.N.A. type laws are intended to guard against. There is a risk that what is science fiction today can become science fact tomorrow.The name Gattaca was derived from the four basic chemical building blocks or nucleotides of DNA: Guanine (G), Adenine (A), Thymine (T), and Cytosine (C).Here is a plot summary of the film: “Vincent is one of the last "natural" babies born into a sterile, genetically-enhanced world, where life expectancy and disease likelihood are ascertained at birth. Myopic and due to die at 30, he has no chance of a career in a society that now discriminates against your genes, instead of your gender, race or religion. Going underground, he assumes the identity of Jerome, crippled in an accident, and achieves prominence in the Gattaca Corporation, where he is selected for his lifelong desire: a manned mission to Saturn's 14th moon (titan). Constantly passing gene tests by diligently using samples of Jerome's hair, skin, blood and urine, his now-perfect world is thrown into increasing desperation, his dream within reach, when the mission director is killed - and he carelessly loses an eyelash at the scene! Certain that they know the murderer's ID, but unable to track down the former Vincent, the police start to close in, with extra searches, and new gene tests. With the once-in-a-lifetime launch only days away, Vincent must avoid arousing suspicion, while passing the tests, evading the police, and not knowing whom he can trust... Written by Cynan Rees <cynanrees@hotmail.com> “
  4. “DTC testing encompasses two separate but related issues: claims made about the tests to induce purchase (e.g., through advertising); and the sale of genetic testing services and provision of test results directly to consumers. In regards to the former, critics argue that consumers are vulnerable to being misled by advertisements and lack the knowledge to make appropriate decisions about whether to get tested or how to interpret the results. Consumers with little knowledge of genetics might have difficulty distinguishing between tests widely used and accepted by medical professionals (such as those for mutations causing cystic fibrosis), and those whose validity is unproven in the scientific literature (such as those purporting to predict risk of depression or an appropriate skin care regimen). Advertisements may also underemphasize the uncertainty of genetic testing results, or exaggerate the risk and severity of a condition for which testing is available, thus increasing consumer anxiety and promoting unnecessary testing. Some companies that advertise tests directly to consumers require that they see their doctors in order to have the tests performed, while others allow individuals to send samples directly to the laboratory and receive the results at home. In the first case health care providers have the opportunity to guide patients away from unneeded tests and to clarify the results when they arrive, although surveys have shown that many health care providers lack adequate knowledge and training to provide quality genetic counseling. Taking tests without a provider’s supervision increases the likelihood of harmful outcomes to consumers, ranging from wasted money to loss of genetic privacy to basing major decisions — such as whether to have a child or take a certain medication — on faulty information. Whether health care provider authorization is required to obtain a genetic test, or any laboratory test, is the province of state law. Some states explicitly authorize laboratories to accept samples from and deliver test results for specific tests (such as cholesterol or pregnancy tests) directly to patients without authorization from a health care provider. Other states categorically prohibit all DTC testing. And still other states are silent on the issue, which leaves it up to individual laboratories to decide whether to offer DTC testing. Currently, 25 states and the District of Columbia permit DTC laboratory testing without restriction, whereas 13 categorically prohibit it. DTC testing for certain specified categories of tests is permitted in 12 states; these laws would likely not extend to genetic tests. It should be noted that even when a health care provider's order is required, the provider may have a conflict of interest if he or she is employed by the laboratory offering the testing. “ The Food and Drug Administration (FDA) has authority to regulate claims made by products under its jurisdiction. However, currently, FDA regulates only those genetic tests that are sold as “test kits” and used by laboratories to perform testing. FDA considers test kits to be medical devices and requires that they undergo premarketreview before they can be made commercially available. Since the vast majority of genetic tests are instead developed by the laboratory, neither tests nor claims made about them is subject to FDA oversight.”John Hopkins, Genetics and Public Policy Center.
  5. The EEOC filed suite against BNSF “for secretly testing its employees for a rare genetic condition that causes carpal tunnel syndrome as one of its symptoms.” BNSF claimed the testing was a way of determining whether the high incidence of repetitive-stress injuries was work related. “Besides testing for this rare problem, company-paid doctors were also instructed to screen for several other medical conditions such as diabetes and alcoholism.” Employees were not told they were being genetically tested and one employee who refused testing was threatened with possible termination. EEOC argued the tests were unlawful under the ADA because they were not job related and any condition of employment based on such tests would be cause for illegal discrimination based on disability.” Thirty six Burlington employees received a total of $2.2 million.The Bloodsaw case raised the question whether a clerical or administrative worker who undergoes a general employee health examination may, without his or her knowledge, be tested for highly private and sensitive medical and genetic information such as syphilis, sickle cell trait, and pregnancy. Lawrence Berkeley Laboratory is a research institution jointly operated by state and federal agencies. Plaintiffs- appellants, present and former employees of Lawrence, allege that in the course of their mandatory employment entrance examinations and on subsequent occasions, Lawrence, without their knowledge or consent, tested their blood and urine for intimate medical conditions -- namely, syphilis, sickle cell trait, and pregnancy. Their complaint asserts that this testing violated Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act (ADA), and their right to privacy as guaranteed by both the United States and State of California Constitutions. The district court granted the defendants-appellees' motions for dismissal, judgment on the pleadings, and summary judgment on all of plaintiffs- appellants' claims. The U.S. Court of Appeals, Ninth Circuit, affirmed as to the ADA claims, but reversed as to the Title VII and state and federal privacy claims.